Last reviewed · How we verify
NCT03850119: NFWHSF
Nanofat on Wound Healing and Scar Formation
NA trial testing Nanofat injection in Scars in 15 participants. Status unknown.
1 September 2021
Quick facts
| Lead sponsor | Universitair Ziekenhuis Brussel |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 15 |
| Start date | 1 March 2019 |
| Primary completion | 1 September 2021 |
| Estimated completion | 1 March 2022 |
Drugs / interventions tested
- Nanofat injection
Conditions studied
- Scars — all drugs for Scars →
- Delayed Wound Healing — all drugs for Delayed Wound Healing →
- Hypertrophic Scar — all drugs for Hypertrophic Scar →
- Post Inflammatory Hyperpigmentation — all drugs for Post Inflammatory Hyperpigmentation →
Sponsor
Universitair Ziekenhuis Brussel — full company profile →
Who can join
Adults 18 to 70, female only, with Scars or Delayed Wound Healing. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will evaluate the effectiveness and safety of intradermal injection of Nanofat on wound healing and scar formation.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Adipose-derived stromal cells for nonhealing wounds: Emerging opportunities and challenges.
Deptuła M, Brzezicka A, Skoniecka A, Zieliński J, et al · · 2021 · cited 38× · PMID 33522005 · DOI 10.1002/med.21789 -
Improvement in Early Scar Maturation by Nanofat Infiltration: Histological and Spectrophotometric Preliminary Results From a Split Scar-Controlled, Randomized, Double-Blinded Clinical Trial.
Ramaut L, Moonen L, Geeroms M, Leemans G, et al · · 2024 · cited 1× · PMID 39360238 · DOI 10.1093/asjof/ojae072
Verify or expand the search:
- PubMed search for NCT03850119
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Scars
Currently open trials in the same condition.
- NCT06868615 — AVAVA MIRIA General Use · NA · recruiting
- NCT06557434 — AV-23-001 AVAVA MIRIA Pilot Study · NA · active not recruiting
- NCT06202274 — Clinical Study to Evaluate the Safety and Efficacy of Candela Technology · NA · active not recruiting
- NCT06122090 — Treatment of Hypopigmented Scars With Bimatoprost · Phase 2 · recruiting
Other Universitair Ziekenhuis Brussel trials
Trials by the same sponsor.
- NCT07536230 — Deep Learning Framework for Continuous Depth of Anesthesia Forecasting · not yet recruiting
- NCT07533968 — The Aim of This Study is to Gain Insight Into the Occurrence of Irritable Bowel Symptoms During Ovarian Stimulation in I · NA · not yet recruiting
- NCT07289984 — Correlation Between Diagnostic Nerve Block Response and Cryoneurolysis Outcome in Chronic Musculoskeletal Disorders and · NA · not yet recruiting
- NCT06923813 — Assessment of Nutrient Absorption in Enterally Fed Post-intensive Care Unit Patients Using Bomb Calorimetry: do the Calo · NA · recruiting
- NCT07401004 — Effect of Blink-Based Training on Cancer Detection in Colorectal Polyp Images by Medical Students/Non GI-trainees · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03850119 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universitair Ziekenhuis Brussel
- Last refreshed: 21 February 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03850119.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing